Literature DB >> 22330168

Commentary: BCG vaccination halves neonatal mortality.

Frank Shann1.   

Abstract

Mesh:

Substances:

Year:  2012        PMID: 22330168     DOI: 10.1097/INF.0b013e3182465be8

Source DB:  PubMed          Journal:  Pediatr Infect Dis J        ISSN: 0891-3668            Impact factor:   2.129


× No keyword cloud information.
  12 in total

Review 1.  Novel adjuvant formulations for delivery of anti-tuberculosis vaccine candidates.

Authors:  Else Marie Agger
Journal:  Adv Drug Deliv Rev       Date:  2015-11-17       Impact factor: 15.470

Review 2.  Heterologous ("nonspecific") and sex-differential effects of vaccines: epidemiology, clinical trials, and emerging immunologic mechanisms.

Authors:  K L Flanagan; R van Crevel; N Curtis; F Shann; O Levy
Journal:  Clin Infect Dis       Date:  2013-04-09       Impact factor: 9.079

3.  Vaccination coverage and out-of-sequence vaccinations in rural Guinea-Bissau: an observational cohort study.

Authors:  Linda Hornshøj; Christine Stabell Benn; Manuel Fernandes; Amabelia Rodrigues; Peter Aaby; Ane Bærent Fisker
Journal:  BMJ Open       Date:  2012-11-19       Impact factor: 2.692

4.  Neonatal BCG vaccination is associated with enhanced T-helper 1 immune responses to heterologous infant vaccines.

Authors:  Daniel H Libraty; Lei Zhang; Marcia Woda; Luz P Acosta; Anamae Obcena; Job D Brion; Rosario Z Capeding
Journal:  Trials Vaccinol       Date:  2014

5.  Child survival and BCG vaccination: a community based prospective cohort study in Uganda.

Authors:  Victoria Nankabirwa; James K Tumwine; Proscovia M Mugaba; Thorkild Tylleskär; Halvor Sommerfelt
Journal:  BMC Public Health       Date:  2015-02-22       Impact factor: 3.295

6.  Early versus late BCG vaccination in HIV-1-exposed infants in Uganda: study protocol for a randomized controlled trial.

Authors:  Victoria Nankabirwa; James K Tumwine; Olive Namugga; Thorkild Tylleskär; Grace Ndeezi; Bjarne Robberstad; Mihai G Netea; Halvor Sommerfelt
Journal:  Trials       Date:  2017-03-31       Impact factor: 2.279

7.  Can earlier BCG vaccination reduce early infant mortality? Study protocol for a cluster randomised trial in Guinea-Bissau.

Authors:  Sanne M Thysen; Aksel Karl Georg Jensen; Amabelia Rodrigues; Igualdino da Silva Borges; Peter Aaby; Christine Benn; Ane Fisker
Journal:  BMJ Open       Date:  2019-09-24       Impact factor: 2.692

8.  BCG coverage and barriers to BCG vaccination in Guinea-Bissau: an observational study.

Authors:  Sanne Marie Thysen; Stine Byberg; Marie Pedersen; Amabelia Rodrigues; Henrik Ravn; Cesario Martins; Christine Stabell Benn; Peter Aaby; Ane Bærent Fisker
Journal:  BMC Public Health       Date:  2014-10-04       Impact factor: 3.295

9.  A Model to Explain How the Bacille Calmette Guérin (BCG) Vaccine Drives Interleukin-12 Production in Neonates.

Authors:  Chido Loveness Kativhu; Daniel H Libraty
Journal:  PLoS One       Date:  2016-08-29       Impact factor: 3.240

10.  Association between live childhood vaccines and COVID-19 outcomes: a national-level analysis.

Authors:  Chikara Ogimi; Pingping Qu; Michael Boeckh; Rachel A Bender Ignacio; Sahar Z Zangeneh
Journal:  medRxiv       Date:  2020-10-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.